Further studies could reveal more mechanisms of SOX17's action in CRC and other cancers, potentially leading to breakthroughs in early cancer diagnosis and treatment, ultimately providing patients with more effective therapeutic options. Here, SOX17 is linked to colorectal carcinoma.